Public-private partnerships in infectious disease surveillance

Infectious Disease Surveillance: Second Edition

Volumn , Issue , 2013, Pages 647-656

  Friede, Andrew ^a  

^a Global Health Sector   (United States)

Author keywords

Contracts; Financing, government; Peer review, research; Population surveillance; Public private sector partnerships

Indexed keywords

EID: 84887252794     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118543504.ch53     Document Type: Chapter

References (14)

1. Micklethwait J, Wooldridge A. The Company: a Short History of a Revolutionary Idea. New York, NY: Modern Library Chronicles, 2003.
2. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001;344:564-72.
3. Jick H, Kaye JA. Autism and DPT vaccination in the United Kingdom. N Engl J Med 2004;350: 2722-3.
4. Centers for Disease Control and Prevention. Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace.MMWR Recomm Rep 2004;53(RR-7):1-12.
5. Communicable Control and Prevention, San Francisco Department of Public Health. Infectious Disease Emergencies: Programs and Activities. San Francisco, CA: San Francisco Department of Public Health, 2011. Available at: http://sfcdcp.org/ideprojects.html. Accessed October 30, 2012.
6. Kimball AM, Moore M, French HM, et al. Regional infectious disease surveillance networks and their potential to facilitate the implementation of the international health regulations. Med Clin North Am 2008;92:1459-71, xii.
7. Bishai DM, Champion C, Steele ME, Thompson L. Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa. Health Aff (Millwood) 2011;30:1058-64.
8. Yäich M. Investing in vaccines for developing countries: how public-private partnerships can confront neglected diseases. Hum Vaccin 2009;5:368-9.
9. Measure DHS. Demographic Heath Surveys. Calverton, MD: Measure DHS, [undated]. Available at: http://www. measuredhs.com/aboutsurveys/dhs/start.cfm. Accessed October 30, 2012.
10. US Agency for International Development (USAID). Health Policy Initiative. Washington, DC: USAID, [undated]. Available at: http://www.healthpolicyini tiative.com/index.cfm?id=index. Accessed October 30, 2012.
11. Kirungi WL, Musinguzi J, Madraa E, et al. Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect 2006;82(Suppl. 1):i36-41.
12. Nkengasong JN, Nsubuga P, Nwanyanwu O, et al. Laboratory systems and services are critical to global health: time to end the neglect? Am J Clin Pathol 2010;134: 368-73.
13. Starr P. The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry. New York, NY: Basic Books, 1982.
14. Securities and Exchange Commission. Disclosure required by sections 406 and 407 of the Sarbanes-Oxley Act of 2002; Correction. 17 CFR Parts 228 and 229. 2003. Available at: http://www.sec.gov/rules/final/33-8177a.htm. Accessed October 30, 2012.